HCI-2184 T24130
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
HCI-2184 is an inhibitor of AXL kinase and Nek2 that acts by successfully mitigating drug resistance in bortezomib-resistant multiple myeloma.
CAS nr:
1341200-61-0
Purity:
98%
Molecular Weight:
502,03
SMILES:
O=S(C1=CC=CC=C1NC2=NC(NC3=CC=C(N4CCN(C)CC4)C=C3)=NC=C2Cl)(N(C)C)=O
Formula:
C23H28ClN7O2S
Pathway:
Target:
